November 9, 2023 C-Path’s Pioneering Neuroscience Workshop Transforms the Landscape of Neurological Disorder Therapies TUCSON, Ariz., Nov. 9, 2023 – Critical Path Institute (C-Path) is pleased to announce the release of a new peer-reviewed publica
November 8, 2023 C-Path Partners with Unite4TB to Create a New Dawn in the Fight Against Tuberculosis C-Path is proud to be part of UNITE4TB, a public-private partnership funded by the Innovative Medicines Initiative and part of the
November 7, 2023 C-Path’s T1D Consortium New-onset Article Published in The Lancet Diabetes and Endocrinology ype 1 Diabetes Consortium, along with external collaborators from Cardiff University and the University of Alberta, today announce
November 6, 2023 ASN PKDOC Poster — November 2023: Despite the regulatory advances in ADPKD including the qualification of total kidney volume (TKV) as a prognostic enrichment bioma
November 1, 2023-November 3, 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting Members of the CDRC team will join the CTOS at The Convention Centre Dublin in Ireland. The Connective Tissue Oncology Society...
October 30, 2023 eCOA Consortium Announces Publication of an Open Access Article C-Path’s eCOA Consortium is pleased to announce the publication of an open access article in Value in Health titled “Best Prac
October 26, 2023-October 27, 2023 C-Path Hosts Its Scientific Breakthrough Summit 2023 The summit featured presentations and panel discussions with C-Path collaborators from industry, academia, global regulatory...
October 26, 2023 C-Path and Congenital Hyperinsulinism International Announce Data Sharing Agreement TUCSON, Ariz., October 26, 2023 — Critical Path Institute (C-Path) and Congenital Hyperinsulinism International (CHI), a leading
October 25, 2023 C-Path Announces Significant Expansion in Neonatal RWD Project Details of the expansion will be a highlight of the Institute’s Scientific Breakthrough Summit Oct. 26-27 in D.C. TUCSON, Ariz.,